Shares of Huons Global Co Ltd. (KOSDAQ:084110) last traded at 41600, representing a move of 1.22%, or 500 per share, on volume of 22,361 shares. After opening the trading day at 41150, shares of Huons Global Co Ltd. traded in a close range. Huons Global Co Ltd. currently has a total float of 10.85 million shares and on average sees 71,443 shares exchange hands each day. The stock now has a 52-week low of 40800 and high of 67600.
South Korea: Korea Composite Stock Price Index (KOSPI)
Korea Composite Stock Price Index (KOSPI) tracks the daily performance of all the stocks on the Stock Market Division of the Korea Exchange. Including Huons Global Co Ltd. shares. That makes it a key indicator of the health of Korean equities.
KOSPI replaced Korea Composite Stock Price Index (KCSPI), which was styled like the Dow Jones of the U.S.The base value of KOSPI was set at 100 points in January1980, though the index wasn’t published until 1983.
KOSPI reached its largest single-day percentage gain of 8.50% (or 23.81 points) on June 17, 1998. That move came at a time when investors were returning to undervalued Asian stocks after a period of financial crisis in the Asian region that started in Thailand. They turned attention to the validity of Huons Global Co Ltd. stocks. The record one-day gain helped KOSPI to recoup most of what it lost during the financial crisis.
However, a few years later KOSPI would record its largest single-day decline of 12.02% (or 64.97 points) on September 12, 2001. But the record one-day decline had much to do with investor panic reaction as it came on the wake of the terror attack in the U.S., popularly known as 9/11. The terror attack cause global panic and triggered widespread stock losses.
KOSPI hit a lifetime low of 93.10 points in January 1981, but recovered steadily over the years to reach a lifetime high of 2228.96 in May 2011.
2000 points milestone
KOSPI moved below 1000 points for many years and only managed to reach the 2000 milestone in July 2007.
Sub-indices
KOSPI has more than 700 constituents. But the broader index has multiple more sharply focused sub-indices under its umbrella. For example, there are sub-indices thattrack the top 200 companies, top 100 companies and top 50 companies in South Korea’s stock market based on market capitalization. Being in the list of KOSPI gives Huons Global Co Ltd. more bonuses.
KOSPI 200, which is the index of the 200 largest companies on Korea’s stock market, tends to move in tandem with the broader all share index KOSPI. That is mainly because KOSPI 200 makes up more than 70% of KOSPI on market capitalization measure. KOSPI 200 is an investible index as it is listed on options and futures markets. Furthermore,KOSPI 200 is one of the world’s most traded indices.
KOSPI 200 was set up with a base value of 100 points. The narrow index first breached the 100 points mark in April 2007. But the index hit its all-time low of 31.96 points in June 1998, around the time Asia was facing one of its worst financial crises.
KOSPI 100 is the index of top 100 largest companies listed on the Korea’s stock market. Its constituents are also components of KOSPI 200.
Appetite for Korea stocks
Domestic and foreign investors are attracted to South Korea stocks as they look to grow wealth while betting on the country’s vibrant export economy. Huons Global Co Ltd. attracts their attention. Retail investors have particularly been jostling for a piece of South Korean equities in the recent times amid bullish economic outlook for the Asian region. Asia-Pacific is projected to account for 26% of the world’s financial wealth by 2019, up from 24% in 2014.Improving corporate governance issues is another attraction to Korea stocks. Authorities in several Asian markets are tightening corporate regulations to make the region attract for foreign direct investment.
Huons Global Co Ltd. provides medical solutions for human health in South Korea and internationally. The company has market cap of $451.43 billion. The firm offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic analgesic and anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and others, as well as circulatory, respiratory, and other tissue cell systems. It currently has negative earnings. It also provides medical devices; eye drops; and bio products.
![](/free-report.png)
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.